($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

BPC157 Nasal Spray


BPC-157 peptide nasal spray presents potential benefits in promoting tissue regeneration, reducing inflammation, and potentially aiding in the management of gastrointestinal and musculoskeletal conditions.

15ml Nasal Spray contains 2mg BPC–157
30ml Nasal Spray contains 4mg BPC–157

486 in stock

First time customer gets 15% discount code = 1storder

BPC-157 Nasal Spray Australia

BPC-157,is a well known synthetic peptide consisting of 15 amino acids, has gained significant attention worldwide due to its primary function of remarkable wound healing properties. This peptide, also known as Body Protection Compound or BPC-157 nasal spray, has been derived from the naturally occurring gastric juice of humans, which aids in food digestion and absorption. Specifically, it is a peptide chain containing 15 amino acids.

Recent research on test subjects has revealed that BPC-157 peptide enhances the expression of growth hormone receptors and exerts its beneficial effects by amplifying the impact of growth hormone in a dose- and time-dependent manner. When combined with other peptides that enhance the availability of human growth hormone, the utilization of Australia BPC-157 from human gastric juice enhances these effects, providing a truly unique and engaging approach to improving overall well-being.

BPC-157 Nasal Spray Benefits Australia

Muscle Development and Regeneration of Damaged Tissues

Recent Australia research has revealed the remarkable muscle-building capabilities of BPC-157 nasal spray. Scientific studies have substantiated these findings, demonstrating tangible benefits. For instance, in one clinical trial scientists witnessed near-complete healing at a faster rate of Achilles tendon injuries in rats following BPC-157 intramuscular injection, whereas the control group failed to fully recover. Another study showcased the accelerated muscle healing effect in rats with crushed muscles through injections of the BPC-157 peptide. These compelling findings underscore the unique and engaging potential of BPC-157.

Blood Pressure Stabilization

In addition, scientific research has demonstrated the effectiveness of BPC-157 in regulating blood pressure. Notably, BPC-157 treatment resulted in lowered blood pressure in rats with chemically induced hypertension. Conversely, when rats were administered L-arginine, a compound that significantly reduces blood pressure, BPC-157 injection led to an increase in blood pressure.

Treatment of Inflammatory Bowel Disease

BPC 157 has shown to be a safe and effective treatment option for inflammatory bowel disease (IBD), due to its anti inflammatory properties as supported by comprehensive scientific research and online references. Additionally, a study revealed that supplementation with BPC 157 successfully reduced inflammation and improved digestive function at a faster rate in rats with irritable bowel syndrome.

Healing Effects

Research shows that BPC-157 has demonstrated amazing healing properties including the repair of damaged tissues, wound healing including skin burns and inflammation reduction. BPC-157 creams exhibited accelerated healing properties in mice with burns, emphasizing its potential therapeutic effects. Furthermore, high doses of Australia BPC 157  demonstrated improved wound healing in rats concurrently treated with corticosteroids.

Moreover, BPC-157 demonstrated its effectiveness in promoting tissue repair in the healing of cuts in both rats and mice, as well as in diabetic rats. This finding is particularly significant, considering the inhibitory effect diabetes has on healing processes.

Additionally, a subcutaneous injection of BPC-157 markedly expedited the healing process of broken bones in rabbits, joint pain and tendon repair highlighting its potential applications in bone injury management.

Antidepressant Therapy 

Scientific research reveals that BPC 157 has promising antidepressant properties, indicating its potential as a potential treatment option for patients. Additionally, animal trials have demonstrated that animal models exposed to chronic pain and stress exhibited significantly improved mobility in a shorter duration compared to rats treated with other antidepressant medications.

Gut Health and Prevention of Gastric Ulcers

Clinical trials have unveiled the remarkable potential of BPC 157  in stimulating the healing process of human stomach ulcers and gastrointestinal fistulas in rats. What’s more, this peptide safeguarded the intestines from toxin-induced damage, including gastric ulcers caused by alcohol. Furthermore, Australia research has shown promising outcomes in terms of BPC 157’s ability to reduce inflammation in rats with rheumatoid arthritis and stomach ulcers. It also exhibited anti-inflammatory effects in subjects with an inflamed esophagus.

Pain in the joints and knees

Emerging Australia research suggests that incorporating BPC-157  into a daily or weekly regimen offers promising results in addressing bone repair and joint health concerns including pain relief. Moreover, a recent study highlights the peptide’s remarkable capacity to expedite soft tissue recovery in the musculoskeletal system and aid the recovery process, while concurrently reducing the potential toxicity associated with commonly used pain-relieving nonsteroidal anti-inflammatory drugs (NSAIDs), such as Aspirin.

Sleep Enhancement

Sleep quality and quantity play a critical role in the body’s recovery and muscle rebuilding after a strenuous workout or injury. While further scientific research is needed to confirm BPC-157’s sleep effects as a sleep aid, the current findings suggest that it is an effective treatment for various health issues. Additionally, one of the potential benefits of BPC-157 could be an improvement in sleep.

Prevention of Liver Disease

Six studies showcase the remarkable effects of BPC-157 on various liver diseases, indicating its potential for therapeutic use. Moreover, a separate study highlights its hepatoprotective properties and suggests that BPC-157 treatment for liver ailments could soon become a reality.

Further, in Australia animal studies showed the utilization of BPC-157 therapy demonstrated significant improvement in jaundice, paws, ears, snout, and yellow abdominal tegmentum within four weeks.

Hence, the findings of Australia researchers imply that BPC-157 nasal sprays hold promise as an innovative approach to tackle liver fibrosis and other liver-related conditions.


BPC-157 is known to have synergistic effects when combined with TB500. Direct SARMs BPC 157 TB 500 blended peptide is available for research purposes.

There is also the option Australia to buy BPC 157 TB500 Nasal Spray, BPC 157 Peptide Vial, BPC 157 Pre Mixed Pen and BPC-157 Capsules.


[1] https://www.ncbi.nlm.nih.gov/ pubmed/21030672

Sequence: Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ma Asp-Asp Ala Gly Leu Val

Molecular Formula: C62H98N16O22


BPC-157 HPLC Certificate

Disclaimer: We do not supply sarms or peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (direct-sarms.com) and provided through Direct Sarms are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.